Publications

Metabolic Modulation Combined with Mtor Pathway Inhibition May Overcame Cutaneous Melanoma Resistance to Mapk Inhibitors Treatment

AuthID
P-00S-Z1Y

Author(s)

Sampaio, C

Domingues, B

Soares, P

Lopes, JM

Populo, H

Document Type

Abstract

Year published

2020

Published

in EUROPEAN JOURNAL OF CANCER, ISSN: 0959-8049

Volume: 138, Pages: S23-S23 (1)

Conference

32Nd Eortc-Nci-Aacr Symposium on Molecular Targets and Cancer Therapeutics, Date: OCT 24-25, 2020, Location: ELECTR NETWORK, Sponsors: European Org Res & Treatment Canc, Natl Canc Inst, Amer Assoc Canc Res

Indexing

Wos^®

Scopus^®

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/s0959-8049(20)31125-4

Scopus: 2-s2.0-85093660981

Wos: WOS:000582839900053

Source Identifiers

ISSN: 0959-8049

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Metabolic Modulation Combined with Mtor Pathway Inhibition May Overcame Cutaneous Melanoma Resistance to Mapk Inhibitors Treatment

Useful Links

Get Help

Federated Authentication (Click on the image)

Metabolic Modulation Combined with Mtor Pathway Inhibition May Overcame Cutaneous Melanoma Resistance to Mapk Inhibitors Treatment

Useful Links

Get Help